About this trial
This study aims to compare the surgical outcomes, safety profiles, and patient satisfaction between two minimally invasive techniques for pelvic organ prolapse repair: Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) mesh-free sacrocolpopexy and laparoscopic mesh-free sacrocolpopexy. By evaluating perioperative data, complication rates, anatomical and functional outcomes, this trial seeks to determine whether the V-NOTES approach provides comparable or superior results to the traditional laparoscopic technique, without the use of synthetic mesh.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who applied to Gaziosmanpaşa Education and Research Hospital, Gynecology and Obstetrics Clinic, who underwent surgery due to symptomatic pelvic organ prolapse with apical and anterior POP Q stage 2 and above, Being over 18 years old Patients who underwent surgery by experienced surgeons
Disqualifiers
Having previously received KT and/or RT due to any malignancy Having previously undergone surgery due to proplasus Patients with severe cardiovascular or respiratory disease
Trial design
Parallel
Treatments tested in this trial
V-NOTES Mesh-Free Sacrocolpopexy
Procedure/SurgeryMesh-free sacrocolpopexy performed via vaginal natural orifice transluminal endoscopic surgery (V-NOTES).
Laparoscopic Mesh-Free Sacrocolpopexy
Procedure/SurgeryMesh-free sacrocolpopexy performed via conventional laparoscopy.
Treatment groups
Trial outcomes
Primary outcomes
Change in Pelvic Organ Prolapse Quantification (POP-Q) stage from baseline to 6 months
Anatomical success will be evaluated using the POP-Q system. A reduction of prolapse stage by at least one level or achieving stage 0-1 will be considered successful.
Change in PISQ-12 Score
Sexual function will be evaluated with PISQ-12. An increase in score indicates improvement.
Change in Pelvic Floor Distress Inventory-20 (PFDI-20) Score
Patient-reported symptoms related to pelvic floor distress will be evaluated using the PFDI-20. A decrease in score indicates improvement in symptoms.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Havva Betül Bacak
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Sponsor institution